Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transarterial carboplatin infusion for hepatocellular carcinoma with massive vessel invasion
jRCTs041180127Recruiting
- Start
- Dec 2014
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of carboplatin in hepatocellular carcinoma (HCC). Primary endpoint: Disease-free survival. Started Dec 2014; status: recruiting.
02
Drugs
carboplatin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on jRCTs041180127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180127.